Category: Biotech
US, UK, and Canada Present 10-point Best Practices...
Posted by Abigale Lormen | Nov 15, 2021 | Biotech | 0
PharmaCyte Biotech Upbeat With $70 Million In Offe...
Posted by Abigale Lormen | Sep 10, 2021 | Biotech | 0
Rosa Hip Completes Zimmer Biomet’s Surgical ...
Posted by Abigale Lormen | Aug 28, 2021 | Biotech | 0
Marinus Anti-Epileptic Drug Enters Third Phase of ...
Posted by Abigale Lormen | Aug 26, 2021 | Biotech | 0
California Hits New Record in Renewable Energy
As of 3:39 pm on April 3rd, California proudly announced that its statewide power grid ran on 97%...
Read MoreUS, UK, and Canada Present 10-point Best Practices on Medical AI
by Abigale Lormen | Nov 15, 2021 | Biotech | 0
With artificial intelligence gaining sway in numerous industries, the US Food and Drug...
Read MorePharmaCyte Biotech Upbeat With $70 Million In Offerings
by Abigale Lormen | Sep 10, 2021 | Biotech | 0
Biotech company PharmaCyte (NASDAQ: PMCB) is having an upbeat run resource-wise. This after it...
Read MoreRosa Hip Completes Zimmer Biomet’s Surgical Robotics Suite
by Abigale Lormen | Aug 28, 2021 | Biotech | 0
Zimmer Bioment’s Rosa Hip medical robotics system has been given the go-signal by the US...
Read MoreMarinus Anti-Epileptic Drug Enters Third Phase of Clinical Trials
by Abigale Lormen | Aug 26, 2021 | Biotech | 0
Ganaxolone, an experimental treatment currently being developed by Marinus Pharmaceuticals is set...
Read MorePharma faces an uphill battle in clinical trial diversity
by Abigale Lormen | Aug 25, 2021 | Biotech | 0
The issue of representation has been spotlighted in politics, sports, and entertainment. Now the...
Read MorePharma faces an uphill battle in clinical trial diversity
by Abigale Lormen | Aug 16, 2021 | Biotech | 0
The issue of representation has been spotlighted in politics, sports, and entertainment. Now the...
Read MoreBioNTech rallies 16% after boosting COVID-19 vaccine sales forecast
by Abigale Lormen | Aug 15, 2021 | Biotech | 0
An increase of about 16% in BioNTech shares was recorded last Monday after the company documented...
Read MoreBiotech Company Illumina Posts Substantial Growth in Q2-2021
by Abigale Lormen | Aug 9, 2021 | Biotech | 0
Diagnostic biotech developer Illumina’s growth in the second quarter of the year bucked...
Read MoreIllumina Under Fire in Europe
by Abigale Lormen | Jul 23, 2021 | Biotech | 0
American biotech innovator Illumina can’t seem to escape from its antitrust woes. It is...
Read MoreKriya Therapeutics lands $100M funding for gene therapy
by Abigale Lormen | Jul 14, 2021 | Biotech | 0
Gene therapy is making a change of focus from rare diseases to mainstream chronic conditions, and...
Read More